CN102441125A - Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae - Google Patents
Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae Download PDFInfo
- Publication number
- CN102441125A CN102441125A CN2011103907106A CN201110390710A CN102441125A CN 102441125 A CN102441125 A CN 102441125A CN 2011103907106 A CN2011103907106 A CN 2011103907106A CN 201110390710 A CN201110390710 A CN 201110390710A CN 102441125 A CN102441125 A CN 102441125A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine preparation
- cerebral apoplexy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention belongs to the field of traditional Chinese medicine preparations, and in particular relates to a traditional Chinese medicine preparation for treating cerebral apoplexy sequelae. The traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 10 parts of astragalus root, 3 parts of chuanxiong rhizome, 3 parts of motherwort, 1 part of leech, 2 parts of long-noded pit viper, 3 parts of coix seed, 3 parts of rhizoma gastrodiae and 2 parts of pseudo-ginseng. The traditional Chinese medicine preparation has the functions of benefiting qi, activating blood circulation, removing blood stasis and dredging collaterals, and has the characteristics of exact treatment effect, high effect taking speed, safety, convenience and no toxic side effect when used for treating cerebral apoplexy sequelae.
Description
Technical field
The invention belongs to field of traditional Chinese, particularly a kind of Chinese medicine preparation of treating the apoplexy sequela.
Background technology
The apoplexy sequela is one type of disease of primary symptom such as, crooked mouth and tongue not smoothgoing with hemiplegia, stiff tongue speech, belongs to the ACVD in the modern medicine.To be healthy energy lose and support from void, blood stasis due to qi deficiency, numbness resistance venation, muscle arteries and veins the main pathogenesis of primary disease, often is divided into the branch of apoplex involving the channels and collaterals and middle internal organs in clinical, and the traditional Chinese medical science is that principle of treatment is treated this disease and obtained promising result through dialectical benefiting QI for activating blood circulation, the eliminating blood stasis and smoothing collaterals taked.
Summary of the invention
Technical problem to be solved by this invention provides a kind of Chinese medicine preparation of treating the apoplexy sequela, the characteristics that have determined curative effect, instant effect, safe ready, have no side effect.
A kind of Chinese medicine preparation of treating the apoplexy sequela of the present invention is characterized in that being processed by following parts by weight of traditional Chinese medicines raw material: 2 parts of 10 parts of the Radixs Astragali, 3 parts of Rhizoma Chuanxiongs, 3 parts of Herba Leonuris, 1 part of Hirudo, 2 parts of Agkistrodons, 3 parts of Semen Coicis, 3 parts in Rhizoma Gastrodiae and Radix Notoginseng.
The present invention can process acceptable various preparations on the Chinese materia medica, preferred capsule.
Method for preparing: processing of medical material is qualified, weighing is assorted, and rolls altogether for fine powder and even, crosses 80 order dusting covers, incapsulates, and every capsules weighs 0.65 gram.
Usage and consumption: oral, one time 8, day clothes three times, 30 days is a course of treatment.
Drug action mechanism of the present invention is following:
The Radix Astragali: tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, inducing diuresis to remove edema, promoting pus discharge and tissue regeneration strengthening are usually used in the card of blood stasis due to qi deficiency clinically.
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping, the hot temperature of loosing of these article is logical, can invigorate blood circulation and can circulation of qi promoting, is the gas medicine in the blood; The sea of blood, outer thorough fur, bypass extremity are pushed up, assigned in the up mountain peak of these article.
Herba Leonuri: blood-activating and qi-promoting, inducing diuresis to remove edema.
Leech: expelling stasis, eliminate disease, the product salty bitter into the blood, the power of good expelling stasis, eliminate disease.
Agkistrodon: dispelling wind and removing obstruction in the collateral, arresting convulsion relieving convulsion, these article power of dispeling the wind is strong, and the dredge the meridian passage of holding concurrently is so be usually used in facial hemiparalysis, hemiplegia etc.
Semen Coicis: promoting diuresis to eliminate damp pathogen, spleen invigorating, eliminating impediment, clearing away heat and discharging pus.These article can win wet again can the Shujin arteries and veins, to relax contraction anxious; Normal and Radix Astragali compatibility strengthens invigorating the spleen and benefiting QI first in clinical, second prevents not understand because of causing contracture with the Radix Astragali excessively, and Zhu Danxi has saying of " muscular contracture contracture, tardiness of speaking in infant stringy pulse adding Semen Coicis ".
Rhizoma Gastrodiae: endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral.
Radix Notoginseng: removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation, these article are usually used in various blood stasis syndromes, can invigorate blood circulation and the dissipating blood stasis that can stop blooding the clinical ischemic cerebrovascular that is usually used in.
Curative effect is judged:
Produce effects: clinical symptom disappearance, limb function obviously improve, and take care of oneself.
Take a turn for the better: cardinal symptom obviously alleviates, limb activity has made marked progress.
Invalid: symptom does not have improvement.
Therapeutic outcome: clinical treatment apoplexy sequela patient 130 examples, take capsule of the present invention, one time 8, day clothes three times, 30 days is a course of treatment.Through three course of therapy produce effects 95 examples, account for 73%, 20 examples that take a turn for the better account for 15%, and invalid 15 examples account for 12%, total effective rate 88%.Shown in treatment, without any side effects to patient, three big routine tests and hepatic and renal function detect no abnormal.
Below enumerate several model cases:
Case 1: patient Xu so-and-so, man, 46 years old; Crooked mouth and tongue, hemiplegia, stiff tongue and retardation in speech, the heavy numbness of brothers behind the apoplexy give Drug therapy of the present invention after three courses of treatment, and symptom disappears basically; Lower limb exercise obviously improves, and life can be taken care of oneself, and follows up a case by regular visits to 1 year symptom and does not increase the weight of.
Case 2: patient Liu so-and-so, man, 50 years old; Examine because of crooked mouth and tongue, hemiplegia, stiff tongue and retardation in speech and to be cerebral thrombosis, give Drug therapy of the present invention after three courses of treatment, symptom disappears basically; Hemiplegia is obviously improved, and life can be taken care of oneself, and follows up a case by regular visits to 1 year symptom and does not increase the weight of.
Case 3: patient king so-and-so, the man 48 years old, examines in local hospital because of hemiplegia and is the apoplexy sequela in May, 2005; Doing well,improvings such as many tame hospitalize hemiplegia, hemianesthesia, crooked mouth and tongue, stiff tongue and retardation in speech are not obvious, and December sensation numb limbs and tense tendons increases the weight of, with dizziness headache; With examining my institute afterwards, give Drug therapy of the present invention after three courses of treatment, symptom disappears basically; Hemiplegia has clear improvement, and can adhere to work, follows up a case by regular visits to 2 years symptoms and does not increase the weight of.
The present invention has following advantage:
(1) Chinese herbal medicine that the present invention selects for use all meets the Pharmacopoeia of People's Republic of China regulation, and the present invention has the effect of benefiting QI for activating blood circulation, eliminating blood stasis and smoothing collaterals according to compatibility.
(2) the present invention not only has therapeutical effect preferably to apoplexy, and can prevent the generation of primary disease.
(3) the present invention is through determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, prescription rigorous and scientific, the characteristics that have determined curative effect, instant effect, have no side effect.
The specific embodiment
Below in conjunction with embodiment the present invention is done and to further describe.
Embodiment
Take by weighing raw material by weight: 2 parts of 10 parts of the Radixs Astragali, 3 parts of Rhizoma Chuanxiongs, 3 parts of Herba Leonuris, 1 part of Hirudo, 2 parts of Agkistrodons, 3 parts of Semen Coicis, 3 parts in Rhizoma Gastrodiae and Radix Notoginseng.
Method for preparing: processing of medical material is qualified, weighing is assorted, and rolls altogether for fine powder and even, crosses 80 order dusting covers, incapsulates, and every capsules weighs 0.65 gram.
Claims (1)
1. Chinese medicine preparation of treating the apoplexy sequela is characterized in that being processed by the raw material of following parts by weight: 2 parts of 10 parts of the Radixs Astragali, 3 parts of Rhizoma Chuanxiongs, 3 parts of Herba Leonuris, 1 part of Hirudo, 2 parts of Agkistrodons, 3 parts of Semen Coicis, 3 parts in Rhizoma Gastrodiae and Radix Notoginseng.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110390710.6A CN102441125B (en) | 2011-11-30 | 2011-11-30 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110390710.6A CN102441125B (en) | 2011-11-30 | 2011-11-30 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102441125A true CN102441125A (en) | 2012-05-09 |
| CN102441125B CN102441125B (en) | 2014-01-15 |
Family
ID=46004385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110390710.6A Active CN102441125B (en) | 2011-11-30 | 2011-11-30 | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441125B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104027559A (en) * | 2014-05-28 | 2014-09-10 | 于恒峰 | Traditional Chinese medicine preparation for treating stroke sequela |
| CN105878769A (en) * | 2014-10-08 | 2016-08-24 | 马中杰 | Medicine formula for preventing cerebral infarction and treating stroke sequelae |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1238186A (en) * | 1998-06-10 | 1999-12-15 | 陈松林 | Medicine for curing hemiplegia and its preparing process |
| CN1554393A (en) * | 2003-12-23 | 2004-12-15 | 山东凤凰制药股份有限公司 | Chinese medicine composition for treating cerebral infarction inacute stage and early recovering stage and preparing process |
| CN101912540A (en) * | 2010-08-20 | 2010-12-15 | 张跃平 | Medicament for treating cerebral infarction |
| CN101954031A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating vascular dementia and preparation method |
| CN101953909A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating cerebral infarction and preparation method thereof |
-
2011
- 2011-11-30 CN CN201110390710.6A patent/CN102441125B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1238186A (en) * | 1998-06-10 | 1999-12-15 | 陈松林 | Medicine for curing hemiplegia and its preparing process |
| CN1554393A (en) * | 2003-12-23 | 2004-12-15 | 山东凤凰制药股份有限公司 | Chinese medicine composition for treating cerebral infarction inacute stage and early recovering stage and preparing process |
| CN101912540A (en) * | 2010-08-20 | 2010-12-15 | 张跃平 | Medicament for treating cerebral infarction |
| CN101954031A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating vascular dementia and preparation method |
| CN101953909A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating cerebral infarction and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104027559A (en) * | 2014-05-28 | 2014-09-10 | 于恒峰 | Traditional Chinese medicine preparation for treating stroke sequela |
| CN105878769A (en) * | 2014-10-08 | 2016-08-24 | 马中杰 | Medicine formula for preventing cerebral infarction and treating stroke sequelae |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102441125B (en) | 2014-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105031088A (en) | Foot bathing powder for treating rheumatoid arthritis and preparation method thereof | |
| CN102178735A (en) | Blood circulation promoting, vein relaxing and obstruction eliminating pills and preparation process thereof | |
| CN102274378B (en) | Brain-strengthening and thrombosis-resisting pills for treating cerebrovascular diseases and preparation method thereof | |
| CN105998432A (en) | Foot bath powder for treating rheumatism and preparation method thereof | |
| CN105031213A (en) | Traditional Chine medicine foot bathing powder for treating arthritis and preparation method thereof | |
| CN103054965B (en) | External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster | |
| CN104758743A (en) | Traditional Chinese medicine foot fumigating powder for treating rheumatism as well as preparation method and using method thereof | |
| CN102441125B (en) | Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae | |
| CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN102670882A (en) | Chinese medicinal preparation for treating facial paralysis through oral administration | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN105770611A (en) | Traditional Chinese medicine composition for neurologically treating Parkinson's disease | |
| CN102125664B (en) | Chinese medicinal preparation for treating cervical spondylosis | |
| CN104491642A (en) | Foot bath powder for preventing and treating gout | |
| CN102475853A (en) | Tan Fu Kang | |
| CN102327524A (en) | Traditional Chinese medicine composition for curing erysipelas | |
| CN104740450A (en) | Traditional Chinese medicine foot bath powder for treating rheumatism and preparation and application method of traditional Chinese medicine foot bath powder | |
| CN102895529A (en) | Medicine treating apoplexy | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN103127283A (en) | Medicine for treating pelvic inflammation | |
| CN102406837A (en) | Traditional Chinese preparation for treating atrophic debilitys | |
| CN102133316B (en) | Chinese medicine pill for treating anorectal diseases | |
| CN102327532B (en) | Capsule for treating rheumatism and rheumatoid arthritis | |
| CN102038928A (en) | Traditional Chinese medicine for treating acute and chronic urticaria and dermatosis | |
| CN101152329A (en) | Medicament for treating flab pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG KANGWEIER BIOCHEMICAL ENGINEERING CO., LTD Free format text: FORMER OWNER: SONG AIMIN Effective date: 20141124 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 256100 ZIBO, SHANDONG PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141124 Address after: 226500, Jiangsu, Rugao Province, such as town 99, Wanshou Road Patentee after: NANTONG KANGWEIERC BIOCHEMICAL CO., LTD. Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China Patentee before: Song Aimin |